Cleared Traditional

K150272 - Capnostream 35 Portable Respiratory Monitor

K150272 is an FDA 510(k) clearance for Capnostream 35 Portable Respiratory Monitor, manufactured by Oridion Medical 1987 , Ltd.. The device is a Class 2 Anesthesiology device with product code CCK cleared through the Traditional 510(k) pathway after a 163-day FDA review.

K150272 · Oridion Medical 1987 , Ltd. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2015
Decision
163d
Days
Class 2
Risk

K150272 is an FDA 510(k) clearance for the Capnostream 35 Portable Respiratory Monitor. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Oridion Medical 1987 , Ltd. (Jerusalem, IL). The FDA issued a Cleared decision on July 17, 2015 after a review of 163 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Oridion Medical 1987 , Ltd. devices

FDA 510(k) Submission Details - K150272

510(k) Number K150272 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 04, 2015
Decision Date July 17, 2015
Days to Decision 163 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
23d slower than avg
Panel avg: 140d · This submission: 163d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCK Device Classification - Class 2, Special Controls

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 230
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K150272.
Westmed Gas Sampling Cannula with O2 delivery
K162343 · Westmed, Inc. · Dec 2016
Nasal CO2 Sample Line, Oral Nasal CO2 Sampling Cannula, O2 Oral/Nasal Co2 Cannula, Sample Lines
K151421 · Salter Labs · Mar 2016
CARESCAPE Respiratory Modules, E-sCO, E-sCOV, E-sCOVX, E-sCAiO, E-sCAiOV, E-sCAiOVX
K150245 · GE Healthcare Finland Oy · Jul 2015
CO2-Mas, Oxygen Delivery/ CO2 sampling cannula style, CO2 sampling only style
K143127 · Dispo-Med (Malaysia) Sdn Bhd · Feb 2015
SOFTECH Plus ETCO2 Cannula
K143469 · Teleflexmedical, Inc. · Feb 2015
CO2 monitoring line with and without in-line filter
K143150 · Besmed Health Business Corp · Feb 2015